Press Releases Sensorion

Equities

ALSEN

FR0012596468

Market Closed - Euronext Paris Other stock markets 10:33:13 2024-04-29 EDT			5-day change	1st Jan Change
0.71 ^EUR	+0.57%		-0.56%	+65.12%

04-08	Sensorion: completion of a private placement	CF
04-05	Sensorion SA announced that it expects to receive ?15 million in funding	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sensorion : Inside Information / Other news releases	04-26	PU
Sensorion Announces its Participation in the American Society of Cell and Gene Therapy (ASGCT) Annual Meeting	04-26	BU
Sensorion : Inside Information / Other news releases	04-10	PU
Sensorion Announces its Participation in the Van Lanschot Kempen's Life Sciences Conference	04-10	BU
Sensorion Announces a €15 Million Financing, Extending Cash Runway Until the End of 2025	04-08	BU
Sensorion Announces the Availability of Its Letter to Shareholders	03-21	BU
Sensorion Announces its Participation in the Annual Bioprocessing Summit Europe	03-15	BU
Sensorion : Annual financial and audit reports / Terms of availability of the annual financial report	03-14	PU
Sensorion Announces the Availability of its Financial Report for 2023	03-14	BU
Sensorion Reports Full-Year 2023 Financial Results and Business Update	03-14	BU
Sensorion Announces it Has Met Primary Endpoint for SENS-401 Phase 2a Clinical Study for Residual Hearing Preservation	03-11	BU
Sensorion : Inside Information / Other news releases	03-06	PU
Sensorion Will Host a Webcast on March 14, 2024, to Announce its 2023 Annual Financial Results	03-06	BU
Sensorion Announces its Participation in the Leerink Partners Global Biopharma Conference	03-01	AQ
Sensorion Announces a EUR50.5 Million Financing with Participation from New and Existing US and European Healthcare Specialist Investors	02-12	AQ
Sensorion Announces its Participation in the Association for Research in Otolaryngology ARO 47th Annual Midwinter Meeting	01-30	AQ
Sensorion Appoints Dr. Federico Mingozzi as Non-Executive Director to the Board of Directors	01-26	AQ
Sensorion Announces Approval to Initiate Lead Gene Therapy Candidate SENS-501 into a Phase 1/2 Clinical Trial in some European Countries	01-22	AQ
Sensorion Publishes Results of Combined General Meeting Resolutions	12-22	AQ
Sensorion Appoints CMC Expert Bernd Schmidt as New Chief Technical Ocer	12-13	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Sensorion

Equities

ALSEN

FR0012596468

Press Releases

Filters